Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer.

[1]  N. L. Heinecke,et al.  PepC: proteomics software for identifying differentially expressed proteins based on spectral counting , 2010, Bioinform..

[2]  E. Wijsman,et al.  A macrophage sterol-responsive network linked to atherogenesis. , 2010, Cell metabolism.

[3]  R. Weichselbaum,et al.  STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy , 2009, PloS one.

[4]  P. Bonnier,et al.  A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays , 2009, International journal of cancer.

[5]  Ole N Jensen,et al.  Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry* , 2009, Molecular & Cellular Proteomics.

[6]  J. Leonard,et al.  Milatuzumab: a promising new agent for the treatment of lymphoid malignancies. , 2009, Expert opinion on investigational drugs.

[7]  S. Narod,et al.  Pattern of metastatic spread in triple-negative breast cancer , 2009, Breast Cancer Research and Treatment.

[8]  L. Carey,et al.  What is triple-negative breast cancer? , 2008, European journal of cancer.

[9]  Z. Xuan,et al.  Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma , 2008, Cell.

[10]  Hemant Ishwaran,et al.  An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer , 2008, Proceedings of the National Academy of Sciences.

[11]  Alexander R. Pico,et al.  WikiPathways: Pathway Editing for the People , 2008, PLoS biology.

[12]  M. Johansson,et al.  Tick‐borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon‐stimulated JAK‐STAT signalling , 2008, Cellular microbiology.

[13]  L. Alldridge,et al.  Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. , 2008, Journal of proteome research.

[14]  A. Tutt,et al.  Triple negative tumours: a critical review , 2007, Histopathology.

[15]  D. Goldenberg,et al.  CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms , 2007, Clinical Cancer Research.

[16]  S. Narod,et al.  Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.

[17]  Wolfgang Heller,et al.  Triple-negative breast cancer: therapeutic options. , 2007, The Lancet. Oncology.

[18]  Bing Zhang,et al.  Association analysis for large-scale gene set data. , 2007, Methods in molecular biology.

[19]  L. Leng,et al.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.

[20]  K. Resing,et al.  Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics*S , 2005, Molecular & Cellular Proteomics.

[21]  Bing Zhang,et al.  WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..

[22]  R. Schreiber,et al.  Interferon-γ and cancer immunoediting , 2005 .

[23]  R. Schreiber,et al.  Interferon-gamma and cancer immunoediting. , 2005, Immunologic research.

[24]  J. Yates,et al.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.

[25]  Bernard Roizman,et al.  STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Leng,et al.  MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.

[27]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Ming Yan,et al.  Protein ISGylation modulates the JAK-STAT signaling pathway. , 2003, Genes & development.

[29]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[30]  Lloyd J. Old,et al.  and shape tumour immunogenicity , 2001 .

[31]  Clement BordierO.  Phase Separation of Integral Membrane Proteins in Triton X-114 Solution , 2001 .

[32]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[33]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Levy,et al.  Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[35]  R. Schreiber,et al.  Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.

[36]  T. Wright,et al.  IFN-gamma induces a p91/Stat1 alpha-related transcription factor with distinct activation and binding properties. , 1995, Journal of immunology.

[37]  R. Cancedda,et al.  Polarized integrin mediates human keratinocyte adhesion to basal lamina. , 1990, Proceedings of the National Academy of Sciences of the United States of America.